Topics

12/11/18

Kenneth E. Leonard, PhD, professor of psychiatry and director of the UB Clinical and Research Institute on Addictions (CRIA), and Peter L. Elkin, MD, professor and chair of biomedical informatics, have been awarded a two-year, $386,013 grant from the National Institute on Alcohol Abuse and Alcoholism to assess what risks may occur for people with alcohol use disorder (AUD) who use prescription painkillers.

12/6/18

Research by Richard M. Gronostajski, PhD, professor of biochemistry, reveals that the absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder.

11/29/18

Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, is using funding from the National Institutes of Health to refine development of computational tools to quantify renal structures in human diabetic nephropathy (DN) biopsies.

11/20/18

Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

11/13/18

Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to New York Gov. Andrew M. Cuomo’s task force that will advise the state on its Hepatitis C Virus (HCV) Elimination Campaign.

10/16/18

Researchers in the Department of Physiology and Biophysics have developed a promising therapy for Duchenne muscular dystrophy (DMD) that is moving closer to use in humans.

10/5/18

The Jacobs School of Medicine and Biomedical Sciences is benefiting from the expansion of clinical trials in Western New York.

10/4/18

Experts have looked at the future of health care in Western New York and the prognosis is positive.

9/19/18
UB researchers have received funding to apply the power of big data to enhance liver health in the Western New York region.

Topics

Clear All Filters